From: Lymphatic vessels assessment in feline mammary tumours
Groups | N° of lymphatics | Spearman test | |
---|---|---|---|
without VEGFR-3 (mean ± st. err; median) | with VEGFR-3 (mean ± st. err; median) | ||
Normal mammary gland | avsb ** | ||
intramammary | 2.43 ± 0.54; 2.16a | 0.79 ± 0.18; 1.03c | cvsd ** |
extramammary | 4.03 ± 0.53; 4.55b | 2.75 ± 0.41; 2.66d | evsf NS |
Benign tumours | gvsh ** | ||
intratumoral | 2.80 ± 0.66; 2.33e | 0.93 ± 0.21; 1.05g | ivsl ** |
extratumoral | 4.20 ± 0.49; 3.76f | 2.64 ± 0.36; 2.53h | mvsn ** |
Malignant tumours | avsevsi NS | ||
intratumoral | 3.76 ± 0.27; 3.50i | 1.30 ± 0.18; 1.10m | bvsfvsl * |
extratumoral | 4.55 ± 0.22; 4.44l | 3.03 ± 0.15; 3.01n | cvsgvsm NS dvshvsn NS |
Malignant tumours intratumoral | |||
Stage 0 | 3.25 ± 0.44; 3.15o | 0.73 ± 0.25; 0.70r | |
Stage I | 4.07 ± 0.47; 3.70p | 1.43 ± 0.42; 0.80s | ovspvsq NS |
Stage II | 5.06 ± 0.51; 4.58q | 3.20 ± 0.34; 3.35t | rvssvst * |
Malignant tumours extratumoral | uvsvvsw NS | ||
Stage 0 | 3.52 ± 0.32; 3.37u | 2.52 ± 0.25; 2.35x | xvsyvsz NS |
Stage I | 5.06 ± 0.51; 4.58v | 3.20 ± 0.34; 3.35y | |
Stage II | 4.59 ± 0.17; 4.52w | 3.12 ± 0.18; 3.15z |